Reduced Susceptibility to Quinolones among Salmonella Serotypes Isolated from Poultry at Slaughter in Venezuela
- 1 September 2007
- journal article
- Published by Elsevier in Journal of Food Protection
- Vol. 70 (9), 2030-2035
- https://doi.org/10.4315/0362-028x-70.9.2030
Abstract
Today there are recognized global “hot spots” that are areas in which nontyphoid Salmonella serotypes have been reported to have a high prevalence of quinolone resistance. There is concern that resistant strains can be disseminated from these localized geographical areas by travelers or via commercial food products. The objective of this article is to report a high frequency of reduced susceptibility to first- and second-generation quinolones among nontyphoid Salmonella isolates from poultry at slaughter in two processing plants belonging to the largest poultry integration companies in Zulia State, Venezuela. Nearly all (74 of 77; 96.1%) of the isolated strains were resistant to nalidixic acid, and 3.7% were resistant to ciprofloxacin; most (45 of 77; 58%) exhibited reduced susceptibility to ciprofloxacin and norfloxacin (15 of 77; 19.5%). In contrast, all of the isolates were susceptible to β-lactamic antimicrobial drugs. Ninety-three percent (72 of 77) of the isolates were either Salmonella Parathyphi B or Salmonella Heidelberg, which have been reported as invasive Salmonella. The predominant serotypes in each slaughter plant showed different antimicrobial susceptibilities, only having in common their high resistance to nalidixic acid, suggesting that different clones disseminated in each commercial integration. The detection of high frequency of reduced susceptibility to first- and second-generation quinolones among nontyphoid Salmonella isolates from fresh poultry during processing is noteworthy. Resistance to quinolone drugs will not only make antimicrobial therapy more complicated if foodborne disease results, but also these quinolone-resistant strains can disseminate from this local hot spot to other geographical areas, spreading the resistance against this important antimicrobial drug.Keywords
This publication has 11 references indexed in Scilit:
- Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997–2004)Diagnostic Microbiology and Infectious Disease, 2006
- New Quinolone Resistance Phenomenon in Salmonella enterica : Nalidixic Acid-Susceptible Isolates with Reduced Fluoroquinolone SusceptibilityJournal of Clinical Microbiology, 2005
- Increasing Prevalence of Quinolone Resistance in Human Nontyphoid Salmonella enterica Isolates Obtained in Spain from 1981 to 2003Antimicrobial Agents and Chemotherapy, 2004
- Emergence of Multidrug-resistantSalmonellaParatyphi B dT+, CanadaEmerging Infectious Diseases, 2004
- InvasiveSalmonellaInfections in the United States, FoodNet, 1996–1999: Incidence, Serotype Distribution, and OutcomeClinical Infectious Diseases, 2004
- Investigation of human infections with Salmonella enterica serovar Java in Scotland and possible association with imported poultryEurosurveillance, 2003
- Reduced Fluoroquinolone Susceptibility in Salmonella enterica Serotypes in Travelers Returning from Southeast AsiaEmerging Infectious Diseases, 2001
- Decreased Susceptibility to Ciprofloxacin inSalmonella entericaserotype Typhi, United KingdomEmerging Infectious Diseases, 2001
- Emerging Mechanisms of Fluoroquinolone ResistanceEmerging Infectious Diseases, 2001
- Emerging Quinolone-Resistant Salmonella in the United StatesEmerging Infectious Diseases, 1997